Mark Dalton

Mark Dalton is a seasoned engineering professional currently serving as Senior Director of Systems Engineering at Mercy BioAnalytics, Inc. since January 2025. Prior positions include Director of Engineering at Day Zero Diagnostics, Inc., and Senior Director of Product Development at Proof Diagnostics, Inc. Mark has extensive experience at T2 Biosystems, where roles encompassed Director and Associate Director of Hardware and Systems Engineering. Prior to that, Mark was a Technical Lead at BD, leading the development of novel genotyping platforms. Academic credentials include a PhD in Continuous Flow Digital PCR and a B.Eng in Biomedical Engineering, both from the University of Limerick, where Mark also held research and teaching positions.